CD4 and metabolic dysfunction-associated steatotic liver disease: We found significantly lower protein levels of Foxp3 [% of CD4+] and FoxP3 [% of CD4+ CD25+] in patients with early MASLD and advanced MASLD compared to higher values in the control group (p < 0.05).